Deltorphin II analogues with 6-hydroxy-2-aminotetralin-2-carboxylic acid in position 1

Journal of Medicinal Chemistry

Volumn 43, Issue 7, 2000, Pages 1359-1366

  Darula, Zsuzsanna ^a   Kövér, Katalin E ^b   Monory, Krisztina ^a   Borsodi, Anna ^a   Makó, Éva ^c   Rónai, András ^c   Tourwé, Dirk ^d   Péter, Antal ^e   Tóth, Géza ^e  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^b UNIVERSITY OF DEBRECEN   (Hungary)

^c SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^d VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^e UNIVERSITY OF SZEGED   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

DELTORPHIN; TETRALIN DERIVATIVE;

ANIMAL TISSUE; ARTICLE; BIOASSAY; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; FRONTAL CORTEX; GUINEA PIG; ILEUM; MOUSE; NONHUMAN; RAT; VAS DEFERENS;

2-NAPHTHYLAMINE; AMINO ACIDS; ANIMALS; ELECTRIC STIMULATION; FRONTAL LOBE; GUINEA PIGS; ILEUM; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MICE; MODELS, MOLECULAR; MOLECULAR CONFORMATION; MUSCLE CONTRACTION; MUSCLE, SMOOTH; OLIGOPEPTIDES; RADIOLIGAND ASSAY; RATS; RATS, WISTAR; RECEPTORS, OPIOID, DELTA; STEREOISOMERISM; STRUCTURE-ACTIVITY RELATIONSHIP; VAS DEFERENS;

EID: 0343183961     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm9911534     Document Type: Article

References (55)

1. 2O, di-tert-butyl dicarbonate; DCM, dichloromethane; DIEA, diisopropylethylamine; HOBt, 1-hydroxybenzotriazole; DCC, dicyclohexylcarbodiimide; DMSO, dimethyl sulfoxide; GITC, 2,3,4,6-tetra-O-acetyl-β-D-glucopyranosyl isothiocyanate; HPLC, high-performance liquid chromatography; TLC, thin-layer chromatography.
2. Hruby, V. J.; Gehrig, C. A. Recent Developments in the Design of Receptor Specific Opioid Peptides. Med. Res. Rev. 1989, 9, 343-401.
3. Schiller, P. W.; Weltrowska, G.; Nguyen, T. M.; Lemieux, C.; Chung, N. N.; Marsden, B. J.; Wilkes, B. C. Conformational Restriction of the Phenylalanine Residue in a Cyclic Opioid Peptide Analogue: Effects on Receptor Selectivity and Stereospecificity. J. Med. Chem. 1991, 34, 3125-3132.
4. Lazarus, L. H.; Bryant, S. D.; Cooper, P. S.; Salvadori, S. What Peptides These Deltorphins Be. Prog. Neurobiol. 1999, 57, 377-420.
5. Erspamer, V.; Melchiorri, P.; Falconieri-Erspamer, G.; Negri, L.; Corsi, R.; Severini, C.; Barra, D.; Simmaco, M.; Kreil G. Deltorphins: a family of naturally occurring peptides with high affinity and selectivity for delta opioid binding sites. Proc. Natl. Acad. Sci. U.S.A. 1989, 86, 5188-5192.
6. 2): a Potent and Fully Specific Agonist for the δ Opioid Receptor. Mol. Pharmacol. 1989, 35, 774-779.
7. Schiller, P. W.; Weltrowska, G.; Nguyen, T. M.; Wilkes, B. C.; Chung, N. N.; Lemieux, C. Conformationally Restricted Deltorphin Analogues. J. Med. Chem. 1992, 35, 3956-3961.
8. 3-Substituted Analogues of Deltorphin C. Spatial Conformation and Topography of the Aromatic Ring in Peptide Recognition by δ Opioid Receptors. J. Med. Chem. 1993, 36, 3748-3756.
9. Tourwé, D.; Verschueren, K; Frycia, A.; Davis, P.; Porreca, F.; Hruby, V.; Toth, G.; Jaspers, H.; Verheyden, P.; Van Binst, G. Conformational Restriction of Tyr and Phe Side chains in Opioid Peptides. Information about Preferred and Bioactive Side chain Topology. Biopolymers 1996, 38, 1-12.
10. 2 with Replacement of Phe by β-MePhe. In Peptides 1994, Proceedings of the 23rd EPS, Maia, H. L. S., Ed.; ESCOM: Leiden, 1995; pp 335-336.
11. 3 Residues on Peptide Recognition for δ-Opioid Receptors. J. Pept. Res. 1997, 50, 48-54.
12. Tóth, G.; Darula, Z.; Péter, A.; Fülöp, F.; Tourwé, D.; Jaspers, H.; Verheyden, P. M. F.; Böcskey, Z.; Tóth, Z.; Borsodi, A. Conformationally Constrained Deltorphin Analogues with 2-Aminotetralin-2-carboxylic acid in Position 3. J. Med. Chem. 1997, 40, 990-995.
13. Lazarus, L. H.; Salvadori, S.; Santagada, V.; Tomatis, R.; Wilson, W. E. Function of Negative Charge in the "Address Domain" of Deltorphins. J. Med. Chem. 1991, 34, 1350-1355.
14. Salvadori, S.; Marastoni, M.; Balboni, G.; Borea, P. A.; Morari, M.; Tomatis, R. Synthesis and Structure-activity Relationships of Deltorphin Analogues. J. Med. Chem. 1991, 34, 1656-1661.
15. Misicka, A.; Lipkowski, A. W.; Fang, L.; Knapp, R. J.; Davis, P.; Kramer, T.; Burks, T. F.; Yamamura, H. I.; Carr, D. B.; Hruby, V. J. Topographical Requirements for Delta Opioid Ligands: Presence of a Carboxyl Group in Position 4 is not Critical for Deltorphin High Delta Receptor Affinity and Analgesic Activity. Biochem. Biophys. Res. Commun. 1991, 180, 1290-1297.
16. Sagan, S.; Charpentier, S.; Delfour, A.; Amiche, M.; Nicolas, P. The Aspartic Acid in Deltorphin I and Dermenkephalin Promotes Targeting to Delta-opioid Receptor Independently of Receptor Binding. Biochem. Biophys. Res. Commun. 1992, 187, 1203-1210.
17. Tancredi, T.; Temussi, P. A.; Picone, D.; Amodeo, P.; Tomatis, R.; Salvadori, S.; Marastoni, M.; Santagada, V.; Balboni, G. New Insights on mu/delta Selectivity of Opioid Peptides: Conformational Analysis of Deltorphin Analogues. Biopolymers 1991, 31, 751-760.
18. Segawa, M.; Ohno, Y.; Doi, M.; Ishida, T.; Iwashita, T. Solution Conformation of mu-Selective Dermorphin and Delta-selective Deltorphin-I in Phospholipid Micelles, Studied by NMR Spectroscopy and Molecular Dynamics Simulations. Int. J. Pept. Protein Res. 1995, 46, 37-46.
19. 2]Deltorphin II Analogues with High Affinity and Selectivity for delta-Opioid Receptor. Biochem. Biophys. Res. Commun. 1991, 180, 822-827.
20. Lazarus, L. H.; Salvadori, S.; Balboni, G.; Tomatis, R.; Wilson, W. E. Stereospecificity of Amino Acid Side Chains in Deltorphin Defines Binding to Opioid Receptors. J. Med. Chem. 1992, 35, 1222-1227.
21. 2]Deltorphin I: Effects on Opioid Receptor Affinities and Activities in vitro and on Antinociceptive Potency. Peptides 1997, 18, 1615-1621.
22. Qian, X.; Kövér, K. E.; Shenderovich, M. D.; Lou, B. S.; Misicka, A.; Zalewska, T.; Horváth, R.; Davis, P.; Bilsky, E. J.; Porreca, F.; Yamamura, H. I.; Hruby, V. J. Newly Discovered Stereochemical Requirements in the Side-chain Conformation of delta Opioid Agonists for Recognizing Opioid Delta Receptors. J. Med. Chem. 1994, 37, 1746-1757.
23. 1]Deltorphin B. Eur. J. Pharmacol. 1996, 302, 37-42.
24. Cardinaux, F.; Pless, J. Morphine-Like Structures and Semirigid Side chains as Molecular Probes for the Bioactive Conformation of Enkephalin. In Peptides 1984. Proceedings of the 18th EPS; Almqvist & Wiksell International: Stockholm, 1984; pp 321-324.
25. Deeks, T.; Crooks, P. A.; Waigh, R. D. Synthesis and Analgesic Properties of two Leucine-Enkephalin Analogues Containing a Conformationally Restrained N-terminal Tyrosine Residue. J. Med. Chem. 1983, 26, 762-765.
26. 5]Enkephalin with Delta Opioid Receptor Selectivity. J. Med. Chem. 1992, 35, 2384-2391.
27. 1 Replacements in the Cyclic δ Receptor Selective Tetrapeptide Tyr-c[D-Cys-Phe-D-Pen]OH (JOM13). J. Med. Chem. 1994, 37, 4371-4383.
28. Rastogi, S. N.; Bindra, J.; Anand, N. α-Methyldopa in a Rigid Framework: 3-Amino-3-methyl-6,7-dihydroxy-3,4-dihydrocoumarins & 2-Amino-6,7-dihydroxytetralin-2-carboxylic acids. Indian J. Chem. 1971, 9, 1175-1182.
29. Péter, A.; Tóth, G.; Olajos, E.; Fülöp, F.; Tourwé, D. Monitoring of Optical Isomers of Some Conformationally Constrained Amino Acids with Tetrahydroisoquinoline or Tetraline Ring Structures. Part II. J. Chromatogr. A 1995, 705, 257-265.
30. Obrecht, D.; Lehmann, C.; Ruffieux, R.; Schönholzer, P.; Müller, K. Novel open-chain and cyclic conformationally constrained (R)-and (S)-α,α-disubstituted tyrosine analogues. Helv. Chim. Acta 1995, 78, 1567-1587.
31. Davis, A. L.; Estcourt, G.; Keeler, J.; Laue, E. D.; Titman, J. J. Improvement of z Filters and Purging Pulses by the Use of Zero-Quantum Dephasing in Inhomogeneous B1 or B0 Fields. J. Magn. Reson. 1993, 105, 167-183.
32. Bax, A.; Davis, D. G. MLEV-17-Based Two-Dimensional Homonuclear Magnetization Transfer Spectroscopy. J. Magn. Reson. 1985, 65, 355-360.
33. Bothner-By, A. A.; Stephens, R. L.; Lee, J.; Warren, C. D.; Jeanloz, R. W. Structure Determination of a Tetrasaccharide: Transient Nuclear Overhauser Effects in the Rotating Frame. J. Am. Chem. Soc. 1984, 106, 811-813.
34. Bax, A.; Davis, D. G. Practical Aspects of Two-Dimensional Transverse NOE Spectroscopy. J. Magn. Reson. 1985, 63, 207-213.
35. Wüthrich, K. NMR of Proteins and Nucleic Acids; Wiley: New York, 1986.
36. Roumestand, C.; Mispelter, J.; Austruy, C.; Canet, D. The Use of Band Filtering in Multidimensional NMR. Evaluation of Two "User-Friendly" Techniques. J. Magn. Reson. 1995, 109, 153-163.
37. Traynor, J. R.; Nahorski, S. R. Modulation by mu-Opioid Agonists of Guanosine-5-O-(3-[35S]thio)triphosphate Binding to Membranes from Human Neuroblastoma SH-SY5Y Cells. Mol. Pharmacol. 1995, 47, 848-854.
38. 1 is Required for δ Selectivity. In Peptides 1994 (Proceedings of the 23rd EPS); Maia, H. L. S., Ed.; ESCOM: Leiden, 1995; pp 700-701.
39. 5,6 Deltorphin II. Neuropeptides 1994, 26, 261-265.
40. Márki, A.; Ötvös, F.; Tóth, G.; Hosztafi, S.; Borsodi, A. Characterization of kappa Opioid Receptors with Tritiated norBNI. Analgesia 1995, 1, 557-560.
41. Sims, J. J.; Selman, L. H.; Cadogan, M. 6-Methoxy-β-tetralone. Org. Synth. 1971, 51, 109
42. Moroder, L.; Hallett, A.; Wunsch, E.; Keller, O.; Wersin, G. Ditert-Butyldicarbonate-Ein Vorteilhaftes Reagenz fur Einfuhrang, der tert-Butoxycarbonyl-schutzgruppe. (Di-tert-butyldicarbonate - An Advanced Reagent for the Introduction of the tert-Butyloxy-carbonyl Protecting Group). Z. Physiol. Chem. Hoppe-Seyler 1976, 357, 1651-1653.
43. Kaiser, F.; Colescott, R. L.; Bossinger, C. D.; Cook, P. I. Color Test for Detection of Free Terminal Amino Groups in Solid-Phase Synthesis of Peptides. Anal. Biochem. 1970, 34, 595-598.
44. Hwang, T. L.; Shaka, A. J. Water Suppression that Works. Excitation Sculpting Using Arbitrary Waveforms and Pulsed Field Gradients. J. Magn. Reson. 1995, 112, 275
45. Bystrov, V. F. Spin-spin Coupling and the Conformational States of Peptide Systems. Prog. Nucl. Magn. Reson. Spectrosc. 1976, 10, 41-48.
46. Pachler, K. G. R. Nuclear Magnetic Resonance Study of Some a-Amino Acids I. Coupling Constants in Alkaline and Acidic Medium. Spectrochim. Acta 1963, 19, 2085-2092.
47. Pachler, K. G. R. Nuclear Magnetic Resonance Study of Some a-Amino Acids II. Rotational Isomerism. Spectrochim. Acta 1964, 20, 581-587.
48. Cung, M. T.; Marraud, M. Conformational Dependence of the Vicinal Proton Coupling Constant for the Cα-Cβ Bond in Peptides. Biopolymers 1982, 21, 953-967.
49. Bax, A. Two-Dimensional NMR and Protein Structure. Annu. Rev. Biochem. 1989, 58, 223-256.
50. Simon, J.; Benyhe, S.; Abutidze, K.; Borsodi, A.; Szûcs, M.; Wollemann, M. Kinetics and Physical Parameters of Rat Brain Opioid Receptors Solubilized by Digitonin and CHAPS. J. Neurochem. 1986, 46, 695-701.
51. Bradford, M. M. A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utiziling the Principle of Dye-Binding. Anal. Biochem. 1986, 72, 248-254.
52. Mansour, A.; Khachaturian, H.; Lewis, M. E.; Akil, H.; Watson, S. J. Anatomy of CNS Opioid Receptors. Trends Neurosci. 1988, 11, 308-317.
53. Kosterlitz, H. W.; Watt, A. J. Kinetic Parameters of Narcotic Agonists, with Particular Reference to N-Allylnoroxymorphone (Naloxone). Br. J. Pharmacol. Chemother. 1968, 33, 266-276.
54. Rónai, A.; Gráf, L.; Székely, I.; Dunai-Kovács, Z.; Bajusz, S. Differential Behaviour of LPH-(61-91)-Peptide in Different Model Systems: Comparison of the Opioid Activities of LPH-(61-91)-Peptide and its Fragments. FEBSLett. 1977, 74, 182-184.
55. Hughes, J.; Smith, T. W.; Kosterlitz, H. W.; Fothergill, L. A.; Morgan, B. A.; Morris, H. R. Identification of Two Related Pentapeptides from the Brain with Potent Opiate Agonist Activity. Nature 1975, 258, 577-580.